Loading ...

Efficacy And Safety Evaluation Of Allergen Immunotherapy Co-Administered With Omalizumab, An Anti-IgE Monoclonal Antibody

(

)

ITN Protocol #:

ITN019AD

Branded Name:

ClinicalTrials.Gov ID:

NCT00078195

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Completed

Summary:

A series of allergy shots may reduce symptoms of seasonal ragweed allergies. This study will determine whether taking a drug called omalizumab (also known as Xolair) before getting the allergy shots is more effective than allergy shots alone or other treatments, such as prescription antihistamines.

Study Personnel:

Protocol Chair

Thomas Casale, MDcasalej@creighton.edu

Work: 

(402)280-4403